ALETHEA CAPITAL MANAGEMENT, LLC

Position in IMRX — Immuneering Corp

CIK 1549408 MERCER ISLAND, WA

Position in IMRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,359,945

+$2,239,078 QoQ

Shares Held

472,935

+1962.1% QoQ

Ownership

0.731%

of shares outstanding

% of Portfolio

0.99%

of 13F equity value

Holder Rank

#11

of 111 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALETHEA CAPITAL MANAGEMENT, LLC holds $185,526,775 across 4 Biotechnology names. IMRX ranks #3 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	648,756	$158,796,006
2	KURA	Kura Oncology, Inc.	2,167,938	$23,782,279
3	IMRX	Immuneering Corp This page	472,935	$2,359,945
4	RNA	Atrium Therapeutics, Inc.	43,758	$588,545

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,359,945	472,935	+1962.1%	Shares	Sole	2026-08-14
2026-03-31	$120,867	22,935	0.0%	Shares	Sole	2026-05-13
2025-12-31	$150,912	22,935	0.0%	Shares	Sole	2026-02-11
2025-09-30	$160,545	22,935	0.0%	Shares	Sole	2025-11-14
2025-06-30	$77,290	22,935	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.